Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 28,476

Document Document Title
WO/2012/101015A1
The present invention relates to an improved process for manufacturing of esters of 2,5-furandicarboxylic acid (FDCA-esters) by reacting 2,5-furandicarboxylic acid (FDCA) with one or more alcohols in the presence of a heterogeneous catal...  
WO/2012/100809A1
The present invention relates to liquid-crystalline compounds having an O-heterocyclic ring, three partly fluorinated benzene rings and a -CF2O- bridge between the rings. The invention also relates to liquid-crystalline media produced th...  
WO/2012/101244A1
Compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (hereinafter referred to as TRPM8), having formula (I), wherein R is selected from: - H, Br, CN, NO2, SO2NH2, SO2NHR' and SO2NR...  
WO/2012/099755A1
The invention provides poly(ethylene glycol)-lipid conjugates for use in drug delivery.  
WO/2012/099952A3
The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, methods of preparation, and use thereof. These compounds are...  
WO/2012/098952A1
Provided is a photoresist composition which comprises a polymer that contains a specific vinylsulfonic acid ester derivative as constituent units and which exhibits improved LWR and can yield a high-resolution pattern. The specific vinyl...  
WO/2012/100179A1
Provided are compounds and methods useful for the preparation of compounds useful as inhibitors of beta-site amyloid precursor protein (APP)-cleaving enzyme.  
WO/2012/099952A2
The present invention relates to benzofuro[3,2-c]pyridine and azepine analogs as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, methods of preparation, and use thereof. These compounds are...  
WO/2012/095375A1
The invention relates to a method for the production of tetrahydrofurane, 1,4-butanediol and/or gamma-butyrolactone by hydrogenation of 1,4-butynediol, characterized in that 1,4-butynediol is evaporated in a hydrogen-containing gas flow ...  
WO/2012/095256A1
The invention relates to a method for the catalytic hydrogenation of 1,4-butynediol at least at the decomposition temperature of 1,4-butynediol to form tetrahydrofurane. According to the method, 1,4-butynediol is evaporated in a hydrogen...  
WO/2012/095777A1
Process for preparing tetrahydrofuran, 1,4-butanediol and/or gamma-butyrolactone by hydrogenation of 1,4-butynediol, wherein 1,4-butynediol is vaporized in a hydrogen-comprising gas stream and hydrogenated in gaseous form over at least o...  
WO/2012/095709A1
The present invention relates to a process for the catalytic hydrogenation of 1,4-butynediol to tetrahydrofuran at at least the decomposition temperature of 1,4-butynediol, wherein 1,4-butynediol is vaporized in a hydrogen-comprising gas...  
WO/2012/093565A1
A method for producing α-amino-γ-butyrolactone or a salt thereof, which comprises a step wherein methionine and a haloacetic acid, namely chloroacetic acid or bromoacetic acid, are caused to react with each other in a solvent, and whic...  
WO/2012/092827A1
Disclosed are cyclic dione derivatives represented by formula (I), wherein the substituents are as defined in the description. The preparation method, intermediate and use thereof are also provided.  
WO/2012/091570A1
A carbohydrate-containing feedstock is converted in a process, which process comprises contacting the feedstock in a first step with an alcohol in the presence of a first acid catalyst at a temperature below 100 °C to yield an intermedi...  
WO/2012/091701A1
Bis-Phenol A (BPA) can now be replaced in industrial processes by BPA substitutes. The BPA substitutes can have structures that are derivatives of BPA. The BPA substitutes can be used in preparing epoxy composition, polycarbonate composi...  
WO/2012/091573A1
A product comprising a furandicarboxylate compound and diol is obtained from a furandicarboxylate containing polyester in a process, which comprises reacting a polymer composition comprising furandicarboxylate containing polyester with w...  
WO/2012/090970A1
Provided is a benzo[b]naphtho[1,2-d]furan compound having a wide band gap which gives excellent color purity of blue. Further provided are a light-emitting element, a light-emitting device, and an electronic device each of which uses the...  
WO/2012/090959A1
The purpose of the present invention is to meet the increasing demands on fine patterns in the microfabrication field, including the manufacture of integrated-circuit elements, by providing: a radiation-sensitive resin composition that n...  
WO/2012/091573A9
A product comprising a furandicarboxylate compound and diol is obtained from a furandicarboxylate containing polyester in a process, which comprises reacting a polymer composition comprising furandicarboxylate containing polyester with w...  
WO/2012/087182A3
The invention relates to novel substituted methyl amines, serotonin 5-HT6 receptor antagonists, active ingredients, pharmaceutical compositions and a method for preventing and treating diseases of the central nervous system, as well as t...  
WO/2012/085056A1
Compounds of the formula (1), wherein, R is hydrogen, alkyl or substituted alkyl, aryl or substituted aryl are useful intermediates in the synthesis of fragrance ingredients such as Ambrox (2).  
WO/2012/085474A1
The present invention relates to a process for preparing chiral amino acids with excellent enantiomeric excesses.  
WO/2012/085170A3
A process for making organoboron compounds is disclosed in which at least one organic compound having at least one Cl, Br, or I atom or at least one nucleophilic leaving group substituent is reacted with at least one boron-containing rea...  
WO/2012/084810A1
The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of specific ruthenium catalysts, or pre-catalysts, in hydrogenation processes for the reduction of ketones and/or aldehydes into the...  
WO/2012/088208A2
Furfural is obtained selectively and in good purity from non-fermentable branched sugars found in soluble waste streams of lignocellulosic biomass. In a monophasic method, stillage or syrup is contacted with water and an acid catalyst un...  
WO/2012/085170A2
A process for making organoboron compounds is disclosed in which at least one organic compound having at least one Cl, Br, or I atom or at least one nucleophilic leaving group substituent is reacted with at least one boron-containing rea...  
WO/2012/088208A3
Furfural is obtained selectively and in good purity from non-fermentable branched sugars found in soluble waste streams of lignocellulosic biomass. In a monophasic method, stillage or syrup is contacted with water and an acid catalyst un...  
WO/2012/085081A1
The present invention relates to a method for controlling invertebrate pests, in particular insects, arthropod pests and nematodes, by using compounds of formula I or II and the salts thereof, the enantiomers thereof and the diastereomer...  
WO/2012/081585A1
The present invention provides a method for diastereo-selectively and enantioselectively producing an optically active alcohol compound indicated in formula (IIIa), etc., that includes hydrogenation of a carbonyl compound indicated in fo...  
WO/2012/081043A8
The present invention relates to a process for the recovery of maleic anhydride from the gas produced by the catalytic oxidation of hydrocarbon, n-butane or benzene, characterized by: d) High efficiency in maleic anhydride recovery e) Re...  
WO/2012/082837A1
The present invention relates to a method of making indeno-fused naphthol materials, that involves, with some embodiments, forming an indanone acid intermediate, which can be represented by the following general Formula V, [Formula V] Wi...  
WO/2012/082633A1
The present invention relates to novel bis-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.  
WO/2012/082665A1
Described herein are single step methods of making various classes of alkylamine derivatives of furan and tetrahydrofuran by simultaneous contact of a sugar with H2, an acid catalyst and hydrogenation catalyst in the presence of an alkyl...  
WO/2012/080243A3
Disclosed herein is novel process for preparation of atovaquone, which process includes reacting1H-2-benzopyran-1,4(3H)-dione with 4-(4-chlorophenyl)cyclohexanecarbaldehyde. The invention further discloses novel intermediates useful in t...  
WO/2012/082513A1
The present invention relates to lactone compounds represented by following Formulas I and II, and methods of making such lactone compounds. Formula (I): and formula (II). The present invention also relates to methods of making other mat...  
WO/2012/082566A1
The present invention relates to novel sulfur derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.  
WO/2012/081043A1
The present invention relates to a process for the recovery of maleic anhydride from the gas produced by the catalytic oxidation of hydrocarbon, n-butane or benzene, characterized by: d) High efficiency in maleic anhydride recovery e) Re...  
WO/2012/077600A1
To provide: a polymerizable compound represented by formula (1) or formula (2); a polymerizable liquid crystal composition which contains the polymerizable compound; a polymer, a coating film and an alignment film, each of which is obtai...  
WO/2012/076985A3
Methods of promoting wound healing in a subject is disclosed. The method include applying a Granzyme B (Granzyme B) inhibitor to the wound. The wound may be a skin wound. The Granzyme B inhibitor may be comprised of nucleic acids, or pep...  
WO/2012/076560A1
The present invention provides a process for preparing primary amines, comprising the steps of A) providing a solution of a primary alcohol in a fluid, non-gaseous phase, B) contacting the phase with free ammonia and/or at least one ammo...  
WO/2012/076985A8
Methods of promoting wound healing in a subject is disclosed. The method include applying a Granzyme B (Granzyme B) inhibitor to the wound. The wound may be a skin wound. The Granzyme B inhibitor may be comprised of nucleic acids, or pep...  
WO/2012/078147A1
A process for preparing 4-[(2R)-2-X-methyl)-3-methylbutyl]-1 -methoxy-2-3(3- methoxypropoxy)-benzene wherein X is a leaving group and use of this compound in the synthesis of aliskiren.  
WO/2012/071708A1
A solid acid catalyst containing Tantalum compound which is suitable for converting a carbohydrate into 5-hydroxymethylfurfural (HMF). The catalyst has high catalytic activity, selectivity and stability in the preparation of HMF by dehyd...  
WO/2012/074190A1
Disclosed is a method for preparing furfural continuously prepared from xylose. In detail, the method for preparing furfural continuously prepared from xylose according to the exemplary embodiments of the present invention can improve th...  
WO/2012/073251A1
A process for producing 2,5-diformylfuran (DFF) by oxidation of 5- hydroxymethylfurfural by utilizing heterogeneous ICaT-4 catalyst in the presence of oxidant such as oxygen, air or oxygen containing gases has been developed. This proces...  
WO/2012/072691A1
The present invention relates to compounds defined by formula (I) wherein the variables R1, R2, R3, m, and n are defined as in claim 1, possessing valuable pharmacological activity. Particularly, the compounds are activators of the recep...  
WO/2012/072489A1
The invention relates to novel alpha,beta-unsaturated imines, to a method for producing same, to the use thereof for combating animal pests, including anthropods and in particular insects, and to the use thereof in vector control.  
WO/2012/069680A1
The present invention relates to a new method for synthesising intermediates of crambescidins and cimipronidine, besides possible derivatives of same. The present invention further relates to reaction intermediates for the synthesis of c...  
WO/2012/068702A1
Disclosed are benzo 5-membered unsaturated heterocyclic compounds represented by formula I and their pharmaceutically acceptable salts, preparation methods and uses thereof in the preparation of the drugs for treating osteoporosis, where...  

Matches 701 - 750 out of 28,476